Your partner in radiopharmacy

Since 2004, Trasis designs, manufactures,  sells and supports high performance synthesizers, dose preparation and dispensing equipment, all related consumables and shielding solutions


Helping the medical community easily access new radiolabeled therapeutic and diagnostic substances.

Our nuclear medicine equipment includes automated synthesizers, dose dispensing systems, their shielding and accessories. We also develop customized synthetic methods and instruments adapted to the evolving needs of the radiochemistry industry.

Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.

See all products

About us

In a  nutshell: designer and manufacturer of radiopharma instruments, ISO 9001-certified company, medical device distributor, close to its customers and partners.

What makes us different: we consider our customers' performance as our own and we put everything in place to improve it.

Our strength:  every aspect of our products: design, manufacturing, commercial service, quality and support is under our full control. Our great multidisciplinary team makes this possible.

Our final goal: enable patients to have access to a wide range of radiotracers in the safest and most timely manner.

Read more

Innovating for nuclear medicine

We develop innovating equipment which enables safe manipulation and quick access to radiolabeled therapeutic and diagnostic substances.

Nuclear Medecine  departements

Drug developers

Drug developers

Nuclear medicine departments

Drug manufacturers

Drug manufacturers

After sales services
After Sales services
Mail US
support_trasis [at] trasis [dot] com

News & Events

Meet us @ EANM

You won’t miss the chance to meet us this year at EANM.

You can make an appointment, meet us on our booth or attend our community meeting.

  • The appointment will leave you for a chosen moment with one of our expert.
  • 29 is our booth #, we will be pleased to listen your radiopharmaceuticals challeges.
  • Our community meeting is the first step to get into the Trasis Community. It is the best way to discover Trasis’ last outcomes in a relaxed atmosphere.


PRESS RELEASE: [18F]FDG Dual radiotracer approved by FDA

Trasis and Shertech Laboratories, received FDA approval of the [18F]FDG Dual process on AllinOne synthesizers.

Trasis and Shertech Laboratories “hand to hand” work was recently rewarded with approval of a supplemental abbreviated New Drug Application and thus receiving a Marketing Authorization from the U.S. Food and Drug Administration for the [18F]FDG Dual process on AllinOne modules.

Scientific Publications

Key facts

Global partners
Approved or demonstrated tracers
exposure reduction
10 Years
Extended warranty for dispensers